05:16 AM EDT, 08/26/2024 (MT Newswires) -- Biora Therapeutics ( BIOR ) filed a registration statement Friday for the potential offering of about 96.7 million of its common shares by certain selling stockholders.

The selling stockholders consist of funds associated with Highbridge Capital Management, funds associated with Anson Investments, Armistice Capital and Sabby Volatility Warrant Master Fund.

The company will not receive any proceeds from the secondary stock offering.